Parse Biosciences Raises $41.5M Series B Round to Scale Sing

Company to commercialize and create single-cell multi-omics products Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series

Related Keywords

Vietnam , Republic Of , Australia , Malaysia , United States , New Zealand , Thailand , Singapore , American , Marshall Wace , Transcriptome Mega , Kostenloser Wertpapierhandel , Charlie Roco , Alex Rosenberg , Shannia Coley , American Society Of Human Genetics , Decode Sciences , Research Instruments Pte Ltd , Janus Henderson , Soleus Capital , Logos Capital , Bioeconomy Capital , Parse Bioscience , Evercode Whole Transcriptome , Evercode Whole Transcriptome Mega , Evercode Whole Transcriptome Mini , Parse Biosciences , Precision Med Tri Conference , Single Cell Transcriptomics , Unprecedented Scale , American Society , Human Genetics , Fsparse , Iosciences , Raises , Series , Hound , Scale , Single , Fell , Sequencing , Products , Xpand , Product , Portfolio ,